The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The prevalence of PIK3CA mutations in gastric and colon cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
The PI3K‒PDK1 connection: more than just a road to PKB
Vanhaesebroeck, B., & Alessi, D. R. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460561 · Cited by 1,644
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,204
Khwaja, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2783 · Cited by 1,039
Whitman, M., Downes, C. P., Keeler, M., Keller, T., & Cantley, L. (1988) · Nature · doi:10.1038/332644a0 · Cited by 1,016
Mutation of the PIK3CA Gene in Ovarian and Breast Cancer
Campbell, I. G., Russell, S. E., Choong, D. Y. H., Montgomery, K. G., Ciavarella, M. L., Hooi, C. S. F., Cristiano, B. E., Pearson, R. B., & Phillips, W. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2933 · Cited by 916
Signaling by Distinct Classes of Phosphoinositide 3-Kinases
Vanhaesebroeck, B., & Waterfield, M. D. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4701 · Cited by 853
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic
Kang, S., Bader, A. G., & Vogt, P. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408864102 · Cited by 823
Phosphatidylinositol 3-kinase: Structure and expression of the 110 kd catalytic subunit
Hiles, I. D., Otsu, M., Volinia, S., Fry, M. J., Gout, I., Dhand, R., Panayotou, G., Ruiz-Larrea, F., Thompson, A., Totty, N. F., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90166-a · Cited by 684
The PIK3CA gene is mutated with high frequency in human breast cancers
Bachman, K. E., Argani, P., Samuels, Y., Silliman, N., Ptak, J., Szabo, S., Konishi, H., Karakas, B., Blair, B. G., Lin, C., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.8.994 · Cited by 665
Structure and function of phosphoinositide 3-kinases
Wymann, M. P., & Pirola, L. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00139-8 · Cited by 660
Purification and characterization of phosphoinositide 3-kinase from rat liver.
Carpenter, C. L., Duckworth, B. C., Auger, K. R., Cohen, B., Schaffhausen, B. S., & Cantley, L. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45429-9 · Cited by 627
Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation.
Rodriguez-Viciana, P., Warne, P. H., Vanhaesebroeck, B., Waterfield, M. D., & Downward, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00602.x · Cited by 566
PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas
Lee, J. W., Soung, Y. H., Kim, S. Y., Lee, H. W., Park, W. S., Nam, S. W., Kim, S. H., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208304 · Cited by 506
Deng, G., Bell, I., Crawley, S., Gum, J., Terdiman, J. P., Allen, B. A., Truta, B., Sleisenger, M. H., & Kim, Y. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1118-3 · Cited by 409
Duval, A., & Hamelin, R. (2002) · PubMed · Cited by 404
Self-citationCarpenter, C. L., Auger, K. R., Chanudhuri, M., Yoakim, M., Schaffhausen, B., Shoelson, S., & Cantley, L. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98375-4 · Cited by 388
Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and Medulloblastomas
Broderick, D. K., Di, C., Parrett, T. J., Samuels, Y. R., Cummins, J. M., McLendon, R. E., Fults, D. W., Velculescu, V. E., Bigner, D. D., & Yan, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1170 · Cited by 337
The activation of phosphatidylinositol 3-kinase by Ras
Kodaki, T., Woscholski, R., Hallberg, B., Rodriguez-Viciana Julian Downward, P., & Parker, P. J. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00177-9 · Cited by 329
Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis
Porter, A. C., & Vaillancourt, R. R. (1998) · Oncogene · doi:10.1038/sj.onc.1202171 · Cited by 320
Using structure to define the function of phosphoinositide 3‐kinase family members
Domin, J., & Waterfield, M. D. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00617-0 · Cited by 233
Samowitz, W. S., Holden, J. A., Curtin, K., Edwards, S. L., Walker, A. R., Lin, H. A., Robertson, M. A., Nichols, M. F., Gruenthal, K. M., Lynch, B. J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64102-8 · Cited by 192
Mutations of PIK3CAin gastric adenocarcinoma
Li, V. S. W., Wong, C. W., Chan, T. L., Chan, A. S. W., Zhao, W., Chu, K.-M., So, S., Chen, X., Yuen, S. T., & Leung, S. Y. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-29 · Cited by 164
BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency
Oliveíra, C., Pinto, M., Duval, A., Louis‐Brennetot, C., Domingo, E., Espín, E., Armengol, M., Yamamoto, H., Hamelin, R., Seruca, R., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1207061 · Cited by 151
Self-citationOliveíra, C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh238 · Cited by 145
Genetic Alterations of Phosphoinositide 3‐kinase Subunit Genes in Human Glioblastomas
Mizoguchi, M., Nutt, C. L., Mohapatra, G., & Louis, D. N. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00080.x · Cited by 136
Koinuma, K., Shitoh, K., Miyakura, Y., Furukawa, T., Yamashita, Y., Ota, J., Ohki, R., Choi, Y. L., Wada, T., Konishi, F., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11523 · Cited by 134
Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation
Domingo, E., Espín, E., Armengol, M., Oliveíra, C., Pinto, M., Duval, A., Louis‐Brennetot, C., Seruca, R., Hamelin, R., Yamamoto, H., et al. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10310 · Cited by 100
Self-citationDeng, G., Peng, E.-Y., Gum, J. R., Terdiman, J. P., Sleisenger, M. H., & Kim, Y. S. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600148 · Cited by 100
Volinia, S., Hiles, I. D., Ormondroyd, E., Nižetić, D., Antonacci, R., Rocchi, M., & Waterfield, M. D. (1994) · Genomics · doi:10.1006/geno.1994.1655 · Cited by 93
Kim, I.-J., Park, J.-H., Kang, H. C., Shin, Y., Park, H., Park, H.-R., Ku, J., Lim, S., & Park, J.-G. (2003) · Human Genetics · doi:10.1007/s00439-003-1027-0 · Cited by 66
Mutations of BRAF and KRAS in gastric cancer and their association with microsatellite instability
Zhao, W., Chan, T. L., Chu, K., Chan, A. S. Y., Stratton, M. R., Yuen, S. T., & Leung, S. Y. (2003) · International Journal of Cancer · doi:10.1002/ijc.11553 · Cited by 41
DNA methylation and gastrointestinal malignancies: functional consequences and clinical implications
Toyota, M., Itoh, F., & Imai, K. (2000) · Journal of Gastroenterology · doi:10.1007/s005350070030 · Cited by 26
Cited by
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Current development of mTOR inhibitors as anticancer agents
Faivre, S., Kroemer, G., & Raymond, E. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2062 · Cited by 1,000
RAS Interaction with PI3K: More Than Just Another Effector Pathway
Castellano, E., & Downward, J. (2011) · Genes & Cancer · doi:10.1177/1947601911408079 · Cited by 762
Oncogenic Mutations of PIK3CA in Human Cancers
Samuels, Y., & Velculescu, V. E. (2004) · Cell Cycle · doi:10.4161/cc.3.10.1164 · Cited by 538
Metadata
- Authors
- Velho, S., Oliveira, C., Ferreira, A., Ferreira, A. C., Suriano, G., Schwartz, S., Duval, A., Carneiro, F., Machado, J. C., Hamelin, R., & Seruca, R.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 41
- Issue
- 11
- Pages
- 1649-1654
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2025221656
- Cited by
- 341
- References
- 36
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.